McNair A, Krogsgaard A R, Hilden T, Nielsen P E
Acta Med Scand. 1986;220(1):15-23. doi: 10.1111/j.0954-6820.1986.tb02725.x.
Emergency treatment of acute, severe hypertension defined as diastolic blood pressure (DBP) greater than or equal to 135 mmHg combined with cerebral symptoms was prospectively monitored in a randomized multicenter study including 64 patients. Treatment was divided into two periods. In the first hour the patients were observed in the supine position after being given 40 mg furosemide intravenously. If DBP remained greater than 125 mmHg (n = 52), the patients were put on fractionated diazoxide administered intravenously (n = 28) or dihydralazine administered intramuscularly (n = 24). Blood pressure (BP) decreased with diazoxide from an average of 241/149 mmHg to 180/111 mmHg after 5 hours and with dihydralazine from 237/149 to 161/101 mmHg. The inter-individual BP response varied considerably. A clear and identical regression in neurological symptoms was observed on both drug regimens. No new neurological symptoms were seen to develop. It is concluded that a gradual fall in BP can be obtained after fractionated dosage of diazoxide (i.v.) as well as after dihydralazine (i.m.). The indication of acute parenteral therapy compared to less aggressive oral treatment is discussed.
在一项纳入64例患者的随机多中心研究中,对定义为舒张压(DBP)大于或等于135 mmHg并伴有脑部症状的急性重症高血压的急诊治疗进行了前瞻性监测。治疗分为两个阶段。在第一个小时,患者静脉注射40 mg呋塞米后仰卧位观察。如果DBP仍大于125 mmHg(n = 52),患者接受静脉分次给予二氮嗪(n = 28)或肌肉注射肼屈嗪(n = 24)。使用二氮嗪后,5小时内血压(BP)从平均241/149 mmHg降至180/111 mmHg,使用肼屈嗪后从237/149 mmHg降至161/101 mmHg。个体间的血压反应差异很大。两种药物治疗方案均观察到神经症状有明显且相同的改善。未发现有新的神经症状出现。结论是,分次给予二氮嗪(静脉注射)以及肼屈嗪(肌肉注射)后可使血压逐渐下降。讨论了与不太积极的口服治疗相比急性肠外治疗的指征。